Study seeks to find the 'Sweet Spot' for prostate surgery success

NCT ID NCT07591688

Not yet recruiting Knowledge-focused Sponsor: Ondokuz Mayıs University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 400 men undergoing HoLEP surgery for an enlarged prostate to see if the percentage of tissue removed (enucleation ratio) predicts how much their symptoms improve after 3 months. Researchers aim to find the minimum ratio needed for meaningful relief, measured by a standard symptom score. The results could help surgeons tailor the procedure for better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help surgeons determine the minimum amount of prostate tissue to remove for reliable symptom improvement after HoLEP surgery.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may vary by surgeon technique and patient factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATE OBSTRUCTION (BPO) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN PROSTATE OBSTRUCTION (BPO)

Contacts and locations

Locations

Ondokuz Mayis University, Faculty of Medicine, Department of Urology

Samsun, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.